IMNM
Price
$9.90
Change
-$0.05 (-0.50%)
Updated
Aug 28 closing price
Capitalization
861.75M
80 days until earnings call
STOK
Price
$19.79
Change
+$0.49 (+2.54%)
Updated
Aug 28, 04:59 PM (EDT)
Capitalization
1.08B
74 days until earnings call
Interact to see
Advertisement

IMNM vs STOK

Header iconIMNM vs STOK Comparison
Open Charts IMNM vs STOKBanner chart's image
Immunome
Price$9.90
Change-$0.05 (-0.50%)
Volume$412.6K
Capitalization861.75M
Stoke Therapeutics
Price$19.79
Change+$0.49 (+2.54%)
Volume$27.54K
Capitalization1.08B
IMNM vs STOK Comparison Chart in %
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. STOK commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a StrongBuy and STOK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (IMNM: $9.90 vs. STOK: $19.77)
Brand notoriety: IMNM and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 47% vs. STOK: 83%
Market capitalization -- IMNM: $861.75M vs. STOK: $1.08B
IMNM [@Biotechnology] is valued at $861.75M. STOK’s [@Biotechnology] market capitalization is $1.08B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, both IMNM and STOK are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 5 TA indicator(s) are bullish while STOK’s TA Score has 4 bullish TA indicator(s).

  • IMNM’s TA Score: 5 bullish, 5 bearish.
  • STOK’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both IMNM and STOK are a good buy in the short-term.

Price Growth

IMNM (@Biotechnology) experienced а -0.50% price change this week, while STOK (@Biotechnology) price change was +0.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

IMNM is expected to report earnings on Nov 17, 2025.

STOK is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($1.08B) has a higher market cap than IMNM($862M). STOK YTD gains are higher at: 79.238 vs. IMNM (-6.780). STOK has higher annual earnings (EBITDA): 42.3M vs. IMNM (-187.92M). IMNM has more cash in the bank: 268M vs. STOK (248M). STOK has less debt than IMNM: STOK (2.3M) vs IMNM (4.14M). STOK has higher revenues than IMNM: STOK (200M) vs IMNM (12.6M).
IMNMSTOKIMNM / STOK
Capitalization862M1.08B80%
EBITDA-187.92M42.3M-444%
Gain YTD-6.78079.238-9%
P/E RatioN/A22.18-
Revenue12.6M200M6%
Total Cash268M248M108%
Total Debt4.14M2.3M180%
FUNDAMENTALS RATINGS
STOK: Fundamental Ratings
STOK
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
10
SEASONALITY SCORE
1..100
39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMNMSTOK
RSI
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bullish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 7 days ago
82%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MITGX33.78N/A
N/A
MFS Massachusetts Investors Tr R1
SLVYX26.87N/A
N/A
Saratoga Large Capitalization Value A
CSVRX44.89N/A
N/A
Columbia Small Cap Value I R
JFCCX35.65N/A
N/A
JHancock Fundamental All Cap Core C
HOORX29.97N/A
N/A
Hartford Schroders US Small Cap Opps R3